Patents
Patents for C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
11/2009
11/12/2009WO2009105755A3 Macrocyclic prodrug compounds useful as therapeutics
11/05/2009WO2009134899A2 Producing biofuels using polyketide synthases
11/03/2009US7612219 11—[ (Z) -3- (dimethylamino) propylidene]—6, 11-dihydro-dibenz [B,E] oxepin-2-YI ]—acetic acid
11/03/2009US7612054 Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
10/2009
10/29/2009WO2009103534A3 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof
10/29/2009US20090270493 prodrugs of gabapentin and pregabalin, such as 2-[1-[[[(2R)-6-oxooxan-2-yl]oxycarbonylamino]methyl]cyclohexyl]aceticacid, used for for treating epilepsy, depression, anxiety, psychosis, brain disorders, neurodegenerative diseases, pain, inflammatory disease, gastrointestinal disorders or drug abuse
10/22/2009US20090263552 Organic Compounds and Methods
10/20/2009CA2168937C Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
10/14/2009EP0941227B2 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent
10/13/2009US7601852 Macrocyclic kinase inhibitors
10/13/2009CA2395866C Ophthalmic anti-allergy compositions suitable for use with contact lenses
10/08/2009US20090253703 Organic compounds
10/08/2009US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders
10/07/2009CN101550126A Epsilon-caprolactone derivative and polymer thereof
09/2009
09/29/2009US7595156 Genes for synthesis of FR-008 polyketides
09/24/2009WO2005113533A9 Process for preparing unsaturated lactones
09/24/2009US20090240068 Methods of making cyclododecatriene and methods of making laurolactone
09/23/2009EP2101755A2 Polyalkyloxydibenz (c,e) oxepine derivatives as medicaments
09/17/2009DE102008014077A1 New borrelidin derivatives are janus kinase 3 inhibitors useful e.g. for treating tumor, microbial infection, immune disorder and ophthalmic disease, inhibiting angiogenesis, and manufacturing herbicides and insecticides against arthropods
09/16/2009EP2100887A1 Lactone-containing compound, polymer, resist composition, and patterning process
09/16/2009CN100540550C Method of stabilizing macrolide compound
09/09/2009CN100536841C Cyclopropyl and cyclobutyl epothilone analogs
09/08/2009US7585889 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure
09/03/2009WO2009105969A1 Epothilone analogues, their pharmaceutical compositions, their use and their preparations
09/01/2009US7582782 Organic compounds
08/2009
08/27/2009WO2009105755A2 Macrocyclic prodrug compounds useful as therapeutics
08/27/2009WO2009103534A2 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof
08/27/2009US20090215858 such as Pentylcarbamic acid 5-oxo-2,3,4,5-tetrahydrobenzo[b]thiepin-4-ylmethyl ester, having a high affinity for vanilloid receptors and/or cannabinoid receptors, used as analgesics or for the treatment of neuropathic pain
08/26/2009EP2093212A1 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof
08/26/2009EP1747211B1 Process for preparing unsaturated lactones
08/26/2009CN101516865A Tertiary alkyl ester of oxodibenzoxepin acetic acid
08/25/2009US7579366 Epothilone derivatives and their synthesis and use
08/18/2009US7576204 (8E,12E,14E)-21-benzoyloxy-3,6-dihydroxy-6,10,12,16,20-pentamethyl-7-((4-methylpiperazin-1-yl)carbonyl)oxy-18,19-epoxytricosa-8,12,14-trien-11-olide; inhibits angiogenesis and inhibits the production of VEGF particularly under hypoxic conditions, which makes it useful as a remedy for solid cancer
08/12/2009CN101506141A 2-(4-methoxycarbonylmethylphenoxymethyl)benzoic acid methyl ester and method for producing the same
08/05/2009EP1742707A4 Treatment of cns disorders using cns target modulators
08/05/2009CN101497595A Method of stabilizing macrolide compound
08/04/2009US7569576 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
08/04/2009US7569535 11-methyl-13-tridecanolide, 12-methyl-14-tetradecanolide and 13-methyl-15-pentadecanolide, perfume compositions containing the same, and process for production of compounds including the same
07/2009
07/30/2009WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof
07/30/2009US20090192215 Cytotoxin Compounds and Methods of Isolation
07/23/2009CA2755876A1 Synthesis of resorcylic acid lactones useful as therapeutic agents
07/22/2009CN101486704A Method for synthesizing muscolide
07/22/2009CN101486675A 2- and 2,5-substituted phenylketoenols
07/16/2009WO2009024103A3 Natural brassinosteroids for use for treating hyperproliferation, treating proliferative diseases and reducing adverse effects of steroid dysfunction in mammals, pharmaceutical composition and its use
07/15/2009EP1765073A4 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof
07/15/2009CN100513387C Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof
07/14/2009US7560252 Borrelidin-producing polyketide synthase and its use
07/09/2009US20090176867 for congenital muscular dystrophy or myopathy resulting from mutations in any of the collagen VI genes selected from the group consisting of Col6A1, Col6A2, and Col6A3; administered orally; normalizes the pathological changes at the ultrastructural level in mitochondria of muscle tissue
07/08/2009EP1073647B1 12,13-cyclopropane epothilone derivatives
07/02/2009WO2009081417A2 Process for preparation of olopat adine hydrochloride
07/02/2009WO2009080504A1 Method for producing ε-caprolactone
07/02/2009US20090170172 Recombinant Methods and Materials for Producing Epothilone and Epothilone Derivatives
07/02/2009US20090169540 Use Of An Antagonist Of Epac For Treating Human Cardiac Hypertrophy
07/02/2009CA2708174A1 Process for preparing e-caprolactone
07/01/2009CN101468977A Phomopsis lactone compounds
06/2009
06/30/2009US7553979 Heat Shock Protein 90 inhibitors; e.g. breast cancer, prostate cancer
06/24/2009EP2072507A1 Tertiary alkyl ester of oxodibenzoxepin acetic acid
06/23/2009US7550503 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy
06/18/2009WO2009075823A1 Intermediates in the synthesis of zearalenone macrolide analogs
06/18/2009WO2009075818A1 Intermediates and methods for making zearalenone macrolide analogs
06/18/2009WO2008156816A3 Renin inhibitors
06/18/2009US20090156836 aromatic diketo derivative which, as glucose 6-phosphatase translocase inhibitor, can be used in the treatment of diabetes mellitus
06/18/2009CA2708143A1 Intermediates in the synthesis of zearalenone macrolide analogs
06/18/2009CA2708141A1 Intermediates and methods for making zearalenone macrolide analogs
06/17/2009EP2070534A2 Cyclopropyl and cyclobutyl epothilone analogs
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/04/2009WO2009040817A3 Salarins and tulearins, compositions and uses thereof
06/04/2009WO2008156817A3 Renin inhibitors
06/03/2009CN101445499A Diterpenoid antitumor compound and preparation method thereof
05/2009
05/28/2009WO2008143730A3 Macrolide compounds and methods of making and using the same
05/27/2009EP2062874A1 Process and intermediates for the preparation of aliskiren
05/27/2009EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators
05/14/2009WO2009059913A1 Method for producing ε-caprolactone
05/14/2009WO2008143729A3 Macrolide compounds and methods of making and using the same
05/14/2009CA2703828A1 Process for preparing .epsilon.-caprolactone
05/13/2009EP2058294A1 2-(4-methoxycarbonylmethylphenoxymethyl)benzoic acid methyl ester and method for producing the same
04/2009
04/30/2009WO2009055519A1 Synthesis of quaternary salt compounds
04/30/2009WO2009055516A1 Synthesis of quaternary salt compounds
04/30/2009WO2009054298A1 Process for production of crystal of dibenzoxepin compound
04/30/2009WO2009054202A1 Process for producing organic compound and organic compound obtained by the same
04/30/2009US20090111151 Production of Polyketides
04/30/2009US20090110718 Derivatives of tiacumicin B as anti-cancer agents
04/30/2009CA2704040A1 Synthesis of quaternary salt compounds
04/30/2009CA2703717A1 Synthesis of quaternary salt compounds
04/29/2009EP1651592B1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
04/29/2009CN101421261A Tetracyclic steroid derivatives useful as progesterone receptor modulators
04/29/2009CN101417992A Synthesis production process of 9-cyclohexadecylene lactone
04/23/2009US20090105327 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds
04/22/2009EP2050442A1 Pharmaceutical composition for prevention and/or treatment of bone disease, functional food or health food comprising the composition, and pharmaceutical preparation comprising the composition as active ingredient
04/22/2009CN101412704A Preparation of epsilon-caprolactone
04/22/2009CN100480389C Production of polyketides
04/16/2009WO2009048086A1 Method for purification of dibenzoxepin compound
04/15/2009EP1711470B1 Malonamide derivatives blocking the activtiy of gamma-secretase
04/14/2009CA2256007C Substituted heterocyclic benzocycloalkenes and their use as analgesic
04/09/2009WO2009044838A1 Method for producing dibenzoxepin compound
04/08/2009EP1448566B3 Chemokine receptor antagonists and methods of use thereof
04/08/2009CN101405280A Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
04/08/2009CN101402628A Synthesis of gamma-undecalactone
04/08/2009CN101402554A 2- and 2,5-substituted phenylketo-enols
04/02/2009WO2009040817A2 Salarins and tulearins, compositions and uses thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 36